REFERENCES
- Boyd, C. J., McCabe S. E., & d'Arcy H. (2003). Ecstasy use among college undergraduates: Gender, race and sexual identity. Journal of Substance Abuse Treatment, 24(3), 209–215.
- Corapcioglu A., & Ogel K. (2004). Factors associated with ecstasy use in Turkish students. Addiction, 99(1), 67–76.
- Degenhardt L., Barker B., & Topp L. (2004). Patterns of ecstasy use in Australia: Findings from a national household survey. Addiction, 99(2), 187–195.
- Degenhardt L., Bruno R., & Topp L. (2010). Is ecstasy a drug of dependence? Drug and Alcohol Dependence, 107(1), 1–10.
- Gouzoulis-Mayfrank E., & Daumann J. (2006). Neurotoxicity of methylenedioxy-amphetamines (MDMA; ecstasy) in humans: How strong is the evidence for persistent brain damage? Addiction, 101(3), 348–361.
- Green, A. R., Mechan, A. O., Elliott, J. M., O'Shea, E., & Colado, M. I. (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). Pharmacological Reviews, 55(3), 463–508.
- Keyes K. M., Martins S. S., & Hasin D. S. (2008). Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: Results from the National Epidemiologic Survey on alcohol and related conditions. Drug and Alcohol Dependence, 97(1–2), 139–149.
- Lim M. S., Hellard M. E., Hocking J. S., Spelman T. D., & Aitken C. K. (2010). Surveillance of drug use among young people attending a music festival in Australia, 2005–2008. Drug and Alcohol Review, 29(2), 150–156.
- Ompad D. C., Galea S., Fuller C. M., Edwards V., & Vlahov D. (2005). Ecstasy use among Hispanic and black substance users in NewYork City. Substance Use & Misuse, 40(9–10), 1399–1407.
- Pedersen W., & Skrondal A. (1999). Ecstasy and new patterns of drug use: A normal population study. Addiction, 94(11), 1695–1706.
- Peters G. J., Kok G., & Schaalma H. P. (2008). Careers in ecstasy use: Do ecstasy users cease of their own accord? Implications for intervention development. BMC Public Health, 8, 376.
- Reinert D. F., & Allen J. P. (2007). The alcohol use disorders identification test: An update of research findings. Alcoholism, Clinical and Experimental Research, 31(2), 185–199.
- Saunders J. B., Aasland O. G., Babor T. F., de la Fuente J. R., & Grant M. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction, 88(6), 791–804.
- The Swedish National Institute of Public Health. (2010). Narkotikabruket i Sverige [Narcotics Use in Sweden]. Ostersund, Sweden: The Swedish National Institute of Public Health.
- Wu L. T., Parrott A. C., Ringwalt C. L., Patkar A. A., Mannelli P., & Blazer D. G. (2009a). The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention. Addictive Behaviors, 34(8), 654–661.
- Wu L. T., Parrott A. C., Ringwalt C. L., Yang C., & Blazer D. G. (2009b). The variety of ecstasy/MDMA users: Results from the National Epidemiologic Survey on alcohol and related conditions. The American Journal of Addictions, 18(6), 452–461.
- Wu L. T., Schlenger W. E., & Galvin D. M. (2006). Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths. Drug and Alcohol Dependence, 84(1), 102–113.